Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Association of the "CDC Guideline for Prescribing Opioids for Chronic Pain" With Emergency Department Opioid Prescribing.

Dayer LE, Breckling MN, Kling BS, Lakkad M, McDade ER, Painter JT.

J Emerg Med. 2019 Nov;57(5):597-602. doi: 10.1016/j.jemermed.2019.07.016. Epub 2019 Oct 5.

PMID:
31594747
2.

Calcium Channel Blockers and Risk of Lymphedema among Breast Cancer Patients: Nested Case-Control Study.

Stolarz AJ, Lakkad M, Klimberg VS, Painter JT.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1809-1815. doi: 10.1158/1055-9965.EPI-19-0448. Epub 2019 Aug 9.

PMID:
31399477
3.

The risk of varenicline-induced seizure among those who have attempted to quit smoking using pharmacotherapy.

Chopra DA, Shah AB, Vadhariya AH, Painter JT.

Epilepsy Behav. 2019 Aug;97:169-173. doi: 10.1016/j.yebeh.2019.05.031. Epub 2019 Jun 26.

PMID:
31252274
4.

Incidence of Clinically Significant Hypotension Stratified by Vasopressin Duration.

Hammond DA, Painter JT, Meena N.

J Intensive Care Med. 2019 Jan;34(1):77-78. doi: 10.1177/0885066617745809. No abstract available.

PMID:
30798676
5.

A recent history of opioid use in the US: Three decades of change.

Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR.

Subst Use Misuse. 2019;54(2):331-339. doi: 10.1080/10826084.2018.1517175. Epub 2018 Dec 21.

PMID:
30572776
6.

Evaluation of an elective course for preparing students to pursue postgraduate residency training.

Hammond DA, Rowe JM, Wiley TL, Painter JT.

Curr Pharm Teach Learn. 2018 Sep;10(9):1264-1271. doi: 10.1016/j.cptl.2018.06.007. Epub 2018 Jun 28.

PMID:
30497630
7.

Testing implementation facilitation of a primary care-based collaborative care clinical program using a hybrid type III interrupted time series design: a study protocol.

Midboe AM, Martino S, Krein SL, Frank JW, Painter JT, Chandler M, Schroeder A, Fenton BT, Troszak L, Erhardt T, Kerns RD, Becker WC.

Implement Sci. 2018 Nov 29;13(1):145. doi: 10.1186/s13012-018-0838-2.

8.

Nonpharmacist Health Care Providers' Knowledge of and Opinions Regarding Medication Costs in Critically Ill Patients.

Hammond DA, Chiu T, Painter JT, Meena N.

Hosp Pharm. 2018 Jun;53(3):188-193. doi: 10.1177/0018578717739005. Epub 2017 Nov 6.

9.

Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock.

Hammond DA, Ficek OA, Painter JT, McCain K, Cullen J, Brotherton AL, Kakkera K, Chopra D, Meena N.

Pharmacotherapy. 2018 May;38(5):531-538. doi: 10.1002/phar.2105. Epub 2018 Apr 30.

PMID:
29600824
10.

Mixed methods formative evaluation of a collaborative care program to decrease risky opioid prescribing and increase non-pharmacologic approaches to pain management.

Becker WC, Mattocks KM, Frank JW, Bair MJ, Jankowski RL, Kerns RD, Painter JT, Fenton BT, Midboe AM, Martino S.

Addict Behav. 2018 Nov;86:138-145. doi: 10.1016/j.addbeh.2018.03.009. Epub 2018 Mar 8.

PMID:
29576479
11.

Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients.

Hammond DA, James TB, Atkinson LN, Painter JT, Lusardi K.

Crit Care Nurse. 2018 Feb;38(1):24-28. doi: 10.4037/ccn2018594.

PMID:
29437075
12.

Consumer willingness to pay for pharmacy services: An updated review of the literature.

Painter JT, Gressler L, Kathe N, Slabaugh SL, Blumenschein K.

Res Social Adm Pharm. 2018 Dec;14(12):1091-1105. doi: 10.1016/j.sapharm.2018.01.010. Epub 2018 Feb 2. Review.

PMID:
29398405
13.

Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research.

Gressler LE, Hammond DA, Painter JT.

J Pain Palliat Care Pharmacother. 2017 Sep - Dec;31(3-4):228-236. doi: 10.1080/15360288.2017.1416440. Epub 2018 Jan 16. Review.

PMID:
29336654
14.

DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case-Control Study.

Kathe N, Shah A, Said Q, Painter JT.

Diabetes Ther. 2018 Feb;9(1):141-151. doi: 10.1007/s13300-017-0353-5. Epub 2017 Dec 13.

15.

Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans.

Gressler LE, Martin BC, Hudson TJ, Painter JT.

Pain. 2018 Mar;159(3):451-459. doi: 10.1097/j.pain.0000000000001111.

PMID:
29189516
16.

Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury.

Hudson TJ, Painter JT, Gressler LE, Lu L, Williams JS, Booth BM, Martin BC, Sullivan MD, Edlund MJ.

Pain Med. 2018 Apr 1;19(4):774-787. doi: 10.1093/pm/pnx208.

17.

Impact of targeted educational interventions on appropriateness of stress ulcer prophylaxis in critically ill adults.

Hammond DA, Killingsworth CA, Painter JT, Pennick RE, Chatterjee K, Boye B, Meena N.

Pharm Pract (Granada). 2017 Jul-Sep;15(3):948. doi: 10.18549/PharmPract.2017.03.948. Epub 2017 Aug 15.

18.

A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications.

Hayes CJ, Painter JT.

J Opioid Manag. 2017 Mar/Apr;13(2):95-103. doi: 10.5055/jom.2017.0373. Review.

PMID:
28829524
19.

Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.

Hammond DA, Cullen J, Painter JT, McCain K, Clem OA, Brotherton AL, Chopra D, Meena N.

J Intensive Care Med. 2017 Jan 1:885066617725255. doi: 10.1177/0885066617725255. [Epub ahead of print]

PMID:
28820036
20.

Comparative Effectiveness of Intra-Articular Hyaluronic Acid and Corticosteroid Injections on the Time to Surgical Knee Procedures.

Shewale AR, Barnes CL, Fischbach LA, Ounpraseuth ST, Painter JT, Martin BC.

J Arthroplasty. 2017 Dec;32(12):3591-3597.e24. doi: 10.1016/j.arth.2017.07.007. Epub 2017 Jul 14.

PMID:
28781020
21.

Perceived Motivating Factors and Barriers for the Completion of Postgraduate Training Among American Pharmacy Students Prior to Beginning Advanced Pharmacy Practice Experiences.

Hammond DA, Oyler DR, Devlin JW, Painter JT, Bolesta S, Swanson JM, Bailey BJ, Branan T, Barletta JF, Dunn B, Haney JS, Juang P, Kane-Gill SL, Kiser TH, Shafeeq H, Skaar D, Smithburger P, Taylor J.

Am J Pharm Educ. 2017 Jun;81(5):90. doi: 10.5688/ajpe81590.

22.

Effects of staff education and standardizing dosing and collection times on vancomycin trough appropriateness in ward patients.

Hammond DA, Atkinson LN, James TB, Painter JT, Lusardi K.

Pharm Pract (Granada). 2017 Apr-Jun;15(2):949. doi: 10.18549/PharmPract.2017.02.949. Epub 2017 Jun 30.

23.

Cost-Effectiveness of Telemedicine-Based Collaborative Care for Posttraumatic Stress Disorder.

Painter JT, Fortney JC, Austen MA, Pyne JM.

Psychiatr Serv. 2017 Nov 1;68(11):1157-1163. doi: 10.1176/appi.ps.201600485. Epub 2017 Jul 3.

PMID:
28669290
24.

Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.

Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, Chopra D, Meena N.

J Intensive Care Med. 2019 Oct;34(10):805-810. doi: 10.1177/0885066617714209. Epub 2017 Jun 15.

PMID:
28618919
25.

Comparison of Low-, Moderate-, and High-Molecular-Weight Hyaluronic Acid Injections in Delaying Time to Knee Surgery.

Shewale AR, Barnes CL, Fischbach LA, Ounpraseuth ST, Painter JT, Martin BC.

J Arthroplasty. 2017 Oct;32(10):2952-2957.e21. doi: 10.1016/j.arth.2017.04.041. Epub 2017 May 2.

26.

Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans.

Hudson TJ, Painter JT, Martin BC, Austen MA, Williams JS, Fortney JC, Sullivan MD, Edlund MJ.

Pain. 2017 Jun;158(6):1039-1045. doi: 10.1097/j.pain.0000000000000874.

27.

Analysis of the Appropriateness of Off-Label Antipsychotic Use for Mental Health Indications in a Veteran Population.

Painter JT, Owen R, Henderson KL, Bauer MS, Mittal D, Hudson TJ.

Pharmacotherapy. 2017 Apr;37(4):438-446. doi: 10.1002/phar.1910. Epub 2017 Mar 21.

PMID:
28164355
28.

Impact of Targeted Educational Interventions on Clostridium difficile Infection Treatment in Critically Ill Adults.

Hammond DA, Hughes CA, Painter JT, Pennick RE, Chatterjee K, Boye B, Meena N.

Hosp Pharm. 2016 Dec;51(11):901-906. doi: 10.1310/hpj5111-901.

29.

Effect of Etomidate on Pneumonia Development in Critically Ill, Nontrauma Patients.

Hammond DA, Vines CE, McPhee AL, Bhandari NR, Jones KM, Meena N, Painter JT.

J Intensive Care Med. 2019 Jan;34(1):34-39. doi: 10.1177/0885066616686052. Epub 2016 Dec 27.

PMID:
28027685
30.

HIV patient and provider feedback on a telehealth collaborative care for depression intervention.

Drummond KL, Painter JT, Curran GM, Stanley R, Gifford AL, Rodriguez-Barradas M, Rimland D, Monson TP, Pyne JM.

AIDS Care. 2017 Mar;29(3):290-298. doi: 10.1080/09540121.2016.1255704. Epub 2016 Nov 22.

PMID:
27871183
31.

Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.

Hammond DA, Smith MN, Painter JT, Meena NK, Lusardi K.

Pharmacotherapy. 2016 May;36(5):463-71. doi: 10.1002/phar.1738. Epub 2016 Apr 1.

PMID:
26952639
33.

Cost-Effectiveness of Collaborative Care for Depression in HIV Clinics.

Painter JT, Fortney JC, Gifford AL, Rimland D, Monson T, Rodriguez-Barradas MC, Pyne JM.

J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):377-85. doi: 10.1097/QAI.0000000000000732.

34.

Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome.

Painter JT, Crofford LJ, Butler JS, Talbert J.

Am J Pharm Benefits. 2014 Nov-Dec;6(6):e177-e184. Epub 2015 Feb 13.

35.

The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems.

Cobaugh DJ, Gainor C, Gaston CL, Kwong TC, Magnani B, McPherson ML, Painter JT, Krenzelok EP.

Am J Health Syst Pharm. 2014 Sep 15;71(18):1539-54. doi: 10.2146/ajhp140157. Review.

PMID:
25174015
36.

Geographic variation of chronic opioid use in fibromyalgia.

Painter JT, Crofford LJ, Talbert J.

Clin Ther. 2013 Mar;35(3):303-11. doi: 10.1016/j.clinthera.2013.02.003. Epub 2013 Feb 26.

37.

Chronic opioid use in fibromyalgia syndrome: a clinical review.

Painter JT, Crofford LJ.

J Clin Rheumatol. 2013 Mar;19(2):72-7. doi: 10.1097/RHU.0b013e3182863447. Review.

PMID:
23364665
38.

Inhibition of transforming growth factor-β-activated kinase-1 blocks cancer cell adhesion, invasion, and metastasis.

Ray DM, Myers PH, Painter JT, Hoenerhoff MJ, Olden K, Roberts JD.

Br J Cancer. 2012 Jun 26;107(1):129-36. doi: 10.1038/bjc.2012.214. Epub 2012 May 29.

39.

Intestinal lymphangiectasis and lipidosis in rats following subchronic exposure to indole-3-carbinol via oral gavage.

Boyle MC, Crabbs TA, Wyde ME, Painter JT, Hill GD, Malarkey DE, Lieuallen WG, Nyska A.

Toxicol Pathol. 2012 Jun;40(4):561-76. doi: 10.1177/0192623311436178. Epub 2012 Feb 9.

PMID:
22328411
40.

Immunohistochemical features of 3,3',4,4'-tetrachloroazobenzene-induced rat gingival lesions.

Ramot Y, Vered M, Malarkey DE, Hooth MJ, Painter JT, Dayan D, Clayton N, Masinde T, Nyska A.

Toxicol Pathol. 2012 Jun;40(4):577-92. doi: 10.1177/0192623311436185. Epub 2012 Feb 7.

PMID:
22317924
41.
42.

Useful immunohistochemical markers of tumor differentiation.

Painter JT, Clayton NP, Herbert RA.

Toxicol Pathol. 2010 Jan;38(1):131-41. doi: 10.1177/0192623309356449. Epub 2009 Dec 22.

43.

Characterization of uterine granular cell tumors in B6C3F1 mice: a histomorphologic, immunohistochemical, and ultrastructural study.

Veit AC, Painter JT, Miller RA, Hardisty JF, Dixon D.

Vet Pathol. 2008 Sep;45(5):654-62. doi: 10.1354/vp.45-5-654.

44.

Hip dysplasia in rabbits: association with nest box flooring.

Owiny JR, Vandewoude S, Painter JT, Norrdin RW, Veeramachaneni DN.

Comp Med. 2001 Feb;51(1):85-8.

PMID:
11926308
45.

The Brown and Williamson documents. Where do we go from here?

Todd JS, Rennie D, McAfee RE, Bristow LR, Painter JT, Reardon TR, Johnson DH Jr, Corlin RF, Coble YD Jr, Dickey NW, et al.

JAMA. 1995 Jul 19;274(3):256-8. No abstract available.

PMID:
7609236
46.

Pap smear screening in family physicians' offices in a rural area with a high cervical cancer rate.

Oleszkowicz KL, Kresch GM, Painter JT.

Fam Med. 1994 Nov-Dec;26(10):648-50.

PMID:
7859958
47.

Shared sacrifice. The AMA leadership response to the Health Security Act.

Painter JT, Bristow LR, Todd JS.

JAMA. 1994 Mar 9;271(10):786-8. No abstract available.

PMID:
8114218
48.

Can the AMA bridge the gap between the specialties?. Interview by C. Burns Roehrig.

Painter JT.

Internist. 1994 Feb;35(2):18-20. No abstract available.

PMID:
10132088
49.

Smoking cessation interventions by family physicians in Texas.

Franklin JL, Williams AF, Kresch GM, Painter JT, Torges K, White J, Grossman O.

Tex Med. 1992 Nov;88(11):60-4.

PMID:
1488724
50.

Texas Cancer Plan: current profile and future directions.

Painter JT, McCrory OF.

Tex Med. 1987 Sep;83(9 Pt 1):66-70. No abstract available.

PMID:
3672396

Supplemental Content

Loading ...
Support Center